Mosanna Therapeutics

Mosanna Therapeutics is a Swiss biotechnology company headquartered in Basel, dedicated to improving patient outcomes and quality of life for diseases with high unmet needs through the application of precision medicine approaches. Innovative drugs are carefully selected and further developed using the best contract research organizations in specific expertise areas. The company’s first goal is to bring an effective and well-tolerated intranasal spray to patients with metabolic obstructive sleep apnea.